{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,26]],"date-time":"2026-02-26T22:15:26Z","timestamp":1772144126392,"version":"3.50.1"},"reference-count":74,"publisher":"Baishideng Publishing Group Inc.","issue":"6","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["WJP"],"published-print":{"date-parts":[[2012]]},"DOI":"10.5498\/wjp.v2.i6.95","type":"journal-article","created":{"date-parts":[[2013,1,26]],"date-time":"2013-01-26T15:44:32Z","timestamp":1359215072000},"page":"95","source":"Crossref","is-referenced-by-count":34,"title":["Platelet biomarkers in Alzheimer\u2019s disease"],"prefix":"10.5498","volume":"2","author":[{"given":"Leda L","family":"Talib","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"2060","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jalz.2006.07.001"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1186\/1479-5876-3-30"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1016\/S1474-4422(06)70355-6"},{"key":"ref4","doi-asserted-by":"crossref","unstructured":"Mattsson N, Andreasson U, Persson S, Arai H, Batish SD, Bernardini S, Bocchio-Chiavetto L, Blankenstein MA, Carrillo MC, Chalbot S. The Alzheimer's Association external quality control program for cerebrospinal fluid biomarkers. Alzheimers Dement 2011;7:386-395.e6.","DOI":"10.1016\/j.jalz.2011.05.2243"},{"key":"ref5","doi-asserted-by":"crossref","unstructured":"Padovani A, Pastorino L, Borroni B, Colciaghi F, Rozzini L, Monastero R, Perez J, Pettenati C, Mussi M, Parrinello G. Amyloid precursor protein in platelets: a peripheral marker for the diagnosis of sporadic AD. Neurology 2001;57:2243-2248.","DOI":"10.1212\/WNL.57.12.2243"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1602\/neurorx.1.2.226"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1016\/0753-3322(93)90031-F"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1016\/j.bcmd.2008.07.003"},{"key":"ref9","unstructured":"Holmsen H. Signal transducing mechanisms in platelets. Proc Natl Sci Counc Repub China B 1991;15:147-152."},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1016\/S0014-5793(03)01015-9"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.3233\/JAD-2011-101641"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.273.43.27765"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.96.7.3922"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1016\/j.jns.2005.09.002s"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1016\/j.mad.2007.11.004"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1196\/annals.1397.082"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1001\/archneur.1996.00550110114019"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1001\/archneur.1997.00550140019007"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1016\/j.neuron.2007.08.008"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.54.10.1907"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.1001\/archneur.59.1.71"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.1007\/s00213-007-0748-5"},{"key":"ref23","doi-asserted-by":"crossref","unstructured":"Embi N, Rylatt DB, Cohen P. Glycogen synthase kinase-2 and phosphorylase kinase are the same enzyme. Eur J Biochem 1979;100:339-347.","DOI":"10.1111\/j.1432-1033.1979.tb04176.x"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.1007\/s00018-005-5597-y"},{"key":"ref25","doi-asserted-by":"crossref","unstructured":"Jope RS, Roh MS. Glycogen synthase kinase-3 (GSK3) in psychiatric diseases and therapeutic interventions. Curr Drug Targets 2006;7:1421-1434.","DOI":"10.2174\/1389450110607011421"},{"key":"ref26","doi-asserted-by":"crossref","unstructured":"Muyllaert D, Kremer A, Jaworski T, Borghgraef P, Devijver H, Croes S, Dewachter I, Van Leuven F. Glycogen synthase kinase-3beta, or a link between amyloid and tau pathology. Genes Brain Behav 2008;7 Suppl 1:57-66.","DOI":"10.1111\/j.1601-183X.2007.00376.x"},{"key":"ref27","doi-asserted-by":"publisher","DOI":"10.1038\/bjp.2008.2"},{"key":"ref28","doi-asserted-by":"publisher","DOI":"10.1016\/S0960-9822(00)00246-3"},{"key":"ref29","doi-asserted-by":"crossref","unstructured":"Frame S, Cohen P. GSK3 takes centre stage more than 20 years after its discovery. Biochem J 2001;359:1-16.","DOI":"10.1042\/bj3590001"},{"key":"ref30","doi-asserted-by":"publisher","DOI":"10.1136\/jnnp.72.2.152"},{"key":"ref31","unstructured":"Kar S, Slowikowski SP, Westaway D, Mount HT. Interactions between beta-amyloid and central cholinergic neurons: implications for Alzheimer's disease. J Psychiatry Neurosci 2004;29:427-441."},{"key":"ref32","doi-asserted-by":"publisher","DOI":"10.1523\/JNEUROSCI.4321-06.2007"},{"key":"ref33","doi-asserted-by":"crossref","unstructured":"Hooper C, Killick R, Lovestone S. The GSK3 hypothesis of Alzheimer's disease. J Neurochem 2008;104:1433-1439.","DOI":"10.1111\/j.1471-4159.2007.05194.x"},{"key":"ref34","doi-asserted-by":"crossref","unstructured":"Grimes CA, Jope RS. The multifaceted roles of glycogen synthase kinase 3beta in cellular signaling. Prog Neurobiol 2001;65:391-426.","DOI":"10.1016\/S0301-0082(01)00011-9"},{"key":"ref35","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.93.16.8455"},{"key":"ref36","doi-asserted-by":"publisher","DOI":"10.1242\/jcs.00384"},{"key":"ref37","doi-asserted-by":"publisher","DOI":"10.1016\/j.brainres.2007.10.064"},{"key":"ref38","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.0500466102"},{"key":"ref39","doi-asserted-by":"publisher","DOI":"10.1590\/S1516-44462010005000002"},{"key":"ref40","doi-asserted-by":"publisher","DOI":"10.1016\/j.jpsychires.2010.06.002"},{"key":"ref41","doi-asserted-by":"publisher","DOI":"10.1016\/j.neulet.2004.10.031"},{"key":"ref42","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2007-09-111518"},{"key":"ref43","doi-asserted-by":"publisher","DOI":"10.1016\/S0197-4580(00)00124-X"},{"key":"ref44","doi-asserted-by":"crossref","unstructured":"Casoli T, Di Stefano G, Balietti M, Solazzi M, Giorgetti B, Fattoretti P. Peripheral inflammatory biomarkers of Alzheimer's disease: the role of platelets. Biogerontology 2010;11:627-633.","DOI":"10.1007\/s10522-010-9281-8"},{"key":"ref45","doi-asserted-by":"crossref","unstructured":"Medina M, Avila J. Glycogen synthase kinase-3 (GSK-3) inhibitors for the treatment of Alzheimer's disease. Curr Pharm Des 2010;16:2790-2798.","DOI":"10.2174\/138161210793176581"},{"key":"ref46","doi-asserted-by":"crossref","unstructured":"Schaeffer EL, Gattaz WF. Cholinergic and glutamatergic alterations beginning at the early stages of Alzheimer disease: participation of the phospholipase A2 enzyme. Psychopharmacology (Berl) 2008;198:1-27.","DOI":"10.1007\/s00213-008-1092-0"},{"key":"ref47","doi-asserted-by":"publisher","DOI":"10.1016\/j.imlet.2008.02.002"},{"key":"ref48","doi-asserted-by":"crossref","unstructured":"Nuutinen T, Suuronen T, Kauppinen A, Salminen A. Clusterin: a forgotten player in Alzheimer's disease. Brain Res Rev 2009;61:89-104.","DOI":"10.1016\/j.brainresrev.2009.05.007"},{"key":"ref49","doi-asserted-by":"crossref","unstructured":"Dröge W. Free radicals in the physiological control of cell function. Physiol Rev 2002;82:47-95.","DOI":"10.1152\/physrev.00018.2001"},{"key":"ref50","doi-asserted-by":"publisher","DOI":"10.1046\/j.1440-1681.2000.03200.x"},{"key":"ref51","doi-asserted-by":"publisher","DOI":"10.1002\/cbf.1516"},{"key":"ref52","doi-asserted-by":"crossref","unstructured":"Dale GL. Coated-platelets: an emerging component of the procoagulant response. J Thromb Haemost 2005;3:2185-2192.","DOI":"10.1111\/j.1538-7836.2005.01274.x"},{"key":"ref53","doi-asserted-by":"publisher","DOI":"10.1080\/09537100500181913"},{"key":"ref54","doi-asserted-by":"publisher","DOI":"10.1097\/WAD.0b013e31811ec11f"},{"key":"ref55","doi-asserted-by":"publisher","DOI":"10.1016\/j.trsl.2008.07.001"},{"key":"ref56","doi-asserted-by":"crossref","unstructured":"Dennis EA. Diversity of group types, regulation, and function of phospholipase A2. J Biol Chem 1994;269:13057-13060.","DOI":"10.1016\/S0021-9258(17)36794-7"},{"key":"ref57","doi-asserted-by":"crossref","unstructured":"Dennis EA. The growing phospholipase A2 superfamily of signal transduction enzymes. Trends Biochem Sci 1997;22:1-2.","DOI":"10.1016\/S0968-0004(96)20031-3"},{"key":"ref58","unstructured":"Bazan NG, Zorumski CF, Clark GD. The activation of phospholipase A2 and release of arachidonic acid and other lipid mediators at the synapse: the role of platelet-activating factor. J Lipid Mediat 1993;6:421-427."},{"key":"ref59","doi-asserted-by":"publisher","DOI":"10.1016\/0955-0674(93)90116-8"},{"key":"ref60","doi-asserted-by":"publisher","DOI":"10.1006\/phrs.1993.1020"},{"key":"ref61","doi-asserted-by":"publisher","DOI":"10.1016\/0006-3223(87)90164-8"},{"key":"ref62","doi-asserted-by":"crossref","unstructured":"Gattaz WF, Schmitt A, Maras A. Increased platelet phospholipase A2 activity in schizophrenia. Schizophr Res 1995;16:1-6.","DOI":"10.1016\/0920-9964(94)00060-L"},{"key":"ref63","doi-asserted-by":"publisher","DOI":"10.1016\/S0006-8993(99)01123-3"},{"key":"ref64","doi-asserted-by":"publisher","DOI":"10.1016\/S0920-9964(02)00281-5"},{"key":"ref65","doi-asserted-by":"publisher","DOI":"10.1046\/j.1471-4159.1998.70020786.x"},{"key":"ref66","doi-asserted-by":"crossref","unstructured":"Gattaz WF, Maras A, Cairns NJ, Levy R, Förstl H. Decreased phospholipase A2 activity in Alzheimer brains. Biol Psychiatry 1995;37:13-17.","DOI":"10.1016\/0006-3223(94)00123-K"},{"key":"ref67","doi-asserted-by":"publisher","DOI":"10.1006\/bbrc.1993.2474"},{"key":"ref68","doi-asserted-by":"publisher","DOI":"10.1016\/j.neulet.2005.12.014"},{"key":"ref69","doi-asserted-by":"publisher","DOI":"10.1007\/BF02189113"},{"key":"ref70","doi-asserted-by":"publisher","DOI":"10.1007\/s00702-004-0142-y"},{"key":"ref71","doi-asserted-by":"publisher","DOI":"10.1007\/s00213-005-2168-8"},{"key":"ref72","doi-asserted-by":"crossref","unstructured":"Petersen RC, Doody R, Kurz A, Mohs RC, Morris JC, Rabins PV, Ritchie K, Rossor M, Thal L, Winblad B. Current concepts in mild cognitive impairment. Arch Neurol 2001;58:1985-1992.","DOI":"10.1001\/archneur.58.12.1985"},{"key":"ref73","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.56.9.1133"},{"key":"ref74","doi-asserted-by":"publisher","DOI":"10.1016\/j.plefa.2008.03.002"}],"container-title":["World Journal of Psychiatry"],"original-title":[],"language":"en","deposited":{"date-parts":[[2022,2,6]],"date-time":"2022-02-06T21:16:38Z","timestamp":1644182198000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.wjgnet.com\/2220-3206\/full\/v2\/i6\/95.htm"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012]]},"references-count":74,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2012]]}},"URL":"https:\/\/doi.org\/10.5498\/wjp.v2.i6.95","relation":{},"ISSN":["2220-3206"],"issn-type":[{"value":"2220-3206","type":"print"}],"subject":[],"published":{"date-parts":[[2012]]}}}